| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ADAMAS PHARMACEUTICALS INC | 2,109,099 | 30,498,000 | 10.94% | ||
| 2 | FIVE PRIME THERAPEUTICS INC | 575,000 | 23,362,000 | 8.38% | ||
| 3 | VANDA PHARMACEUTICALS INC COM | 2,731,210 | 22,833,000 | 8.19% | ||
| 4 | ZOGENIX INC | 2,085,959 | 19,274,000 | 6.92% | ||
| 5 | TETRAPHASE PHARMACEUTICALS I COM | 3,653,200 | 16,914,000 | 6.07% | ||
| 6 | BLUEBIRD BIO INCORPORATED | 393,135 | 16,708,000 | 6.00% | ||
| 7 | EXELIXIS INC | 3,896,113 | 15,584,000 | 5.59% | ||
| 8 | NEUROCRINE BIOSCIE COM USD0.001 | 325,300 | 12,866,000 | 4.62% | ||
| 9 | INTERCEPT PHARMACEUTICAL | 100,000 | 12,847,000 | 4.61% | Put | |
| 10 | VERICEL CORP | 2,110,738 | 12,369,000 | 4.44% | ||
| 11 | CONNECTURE INC COM | 4,127,232 | 10,566,000 | 3.79% | ||
| 12 | ALCOBRA LTD | 2,020,166 | 7,656,000 | 2.75% | ||
| 13 | AURINIA PHARMACEUTICALS INC | 2,457,144 | 7,187,000 | 2.58% | ||
| 14 | XENCOR INC COM | 528,692 | 7,095,000 | 2.55% | ||
| 15 | AVALANCHE BIOTECHNOLOGIES IN | 1,295,416 | 6,697,000 | 2.40% | ||
| 16 | CHIMERIX INC | 1,300,000 | 6,643,000 | 2.38% | ||
| 17 | RAPTOR PHARMACEUTICAL CORP | 1,346,344 | 6,193,000 | 2.22% | ||
| 18 | SYNERGY PHARMACEUTICALS DEL COM NEW | 2,175,000 | 6,003,000 | 2.15% | ||
| 19 | OCERA THERAPEUTICS INC | 1,963,777 | 5,774,000 | 2.07% | ||
| 20 | PARATEK PHARMACEUTICALS INC | 305,459 | 4,634,000 | 1.66% | ||
| 21 | Bovie Medical Corp | 2,680,000 | 4,476,000 | 1.61% | ||
| 22 | Sunesis Pharmaceuticals I | 8,250,000 | 4,455,000 | 1.60% | ||
| 23 | ARADIGM CORP COM | 1,002,962 | 4,453,000 | 1.60% | ||
| 24 | SAREPTA THERAPEUTICS INC | 150,000 | 2,928,000 | 1.05% | Call | |
| 25 | ACADIA PHARMACEUTICALS INC COM | 100,000 | 2,796,000 | 1.00% | ||
| 26 | TENAX THERAPEUTICS INC COM | 1,108,593 | 2,273,000 | 0.82% | ||
| 27 | IGNYTA INC COM | 287,173 | 1,944,000 | 0.70% | ||
| 28 | Caladrius Biosciences Inc | 1,710,600 | 1,283,000 | 0.46% | ||
| 29 | PORTOLA PHARMACEUTICALS INC | 50,000 | 1,020,000 | 0.37% | ||
| 30 | PORTOLA PHARMACEUTICALS INC | 29,300 | 598,000 | 0.21% | Call | |
| 31 | RIGEL PHARMACEUTICAL INC | 157,872 | 328,000 | 0.12% | ||
| 32 | STREAMLINE HEALTH SOLUTIONS COM | 151,611 | 214,000 | 0.08% | ||
| 33 | Life Technologies Corp | 49,906 | 197,000 | 0.07% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000930413-16-007144, filed 2016.05.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
